CS653586A3 - Pharmaceutical containing 7-isopropoxyisoflavone - Google Patents

Pharmaceutical containing 7-isopropoxyisoflavone

Info

Publication number
CS653586A3
CS653586A3 CS866535A CS653586A CS653586A3 CS 653586 A3 CS653586 A3 CS 653586A3 CS 866535 A CS866535 A CS 866535A CS 653586 A CS653586 A CS 653586A CS 653586 A3 CS653586 A3 CS 653586A3
Authority
CS
Czechoslovakia
Prior art keywords
inclusion complexes
active ingredient
isopropoxyisoflavone
cyclodextrin
pharmaceutical containing
Prior art date
Application number
CS866535A
Other languages
English (en)
Other versions
CS276944B6 (en
Inventor
Agnes Stadler
Jozsef Szejtli
Viktor Weiszfeiler
Zolt Ny N Vargay
Katalin Kaloy
Vera Gergely
Tamas Szuets
Original Assignee
Stadler Agnes Ing
Szejtli Jozsef Dr
Weiszfeiler Viktor Dr
Vargay Zoltan Dr
Kaloy Katalin Dr
Gergely Vera Dr
Szuts Tamas Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stadler Agnes Ing, Szejtli Jozsef Dr, Weiszfeiler Viktor Dr, Vargay Zoltan Dr, Kaloy Katalin Dr, Gergely Vera Dr, Szuts Tamas Dr filed Critical Stadler Agnes Ing
Publication of CS276944B6 publication Critical patent/CS276944B6/cs
Publication of CS653586A3 publication Critical patent/CS653586A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS866535A 1985-09-10 1986-09-10 Pharmaceutical containing 7-isopropoxyisoflavone CS653586A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU853415A HU199444B (en) 1985-09-10 1985-09-10 Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom

Publications (2)

Publication Number Publication Date
CS276944B6 CS276944B6 (en) 1992-10-14
CS653586A3 true CS653586A3 (en) 1992-10-14

Family

ID=10963942

Family Applications (1)

Application Number Title Priority Date Filing Date
CS866535A CS653586A3 (en) 1985-09-10 1986-09-10 Pharmaceutical containing 7-isopropoxyisoflavone

Country Status (16)

Country Link
US (2) US4826963A (cs)
EP (1) EP0214647B1 (cs)
JP (1) JPH0688993B2 (cs)
KR (1) KR900000542B1 (cs)
CN (1) CN1006889B (cs)
AT (1) ATE87319T1 (cs)
CA (1) CA1288424C (cs)
CS (1) CS653586A3 (cs)
DD (1) DD254939A5 (cs)
DE (1) DE3688114D1 (cs)
FI (1) FI86958C (cs)
HU (1) HU199444B (cs)
PL (1) PL261349A1 (cs)
RU (1) RU2022970C1 (cs)
SU (1) SU1757472A3 (cs)
UA (1) UA19813A (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
DE3809808A1 (de) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
JPH02142709A (ja) * 1988-11-24 1990-05-31 Kurita Water Ind Ltd 有害生物防除剤
WO1991004026A1 (en) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
WO1991013100A1 (en) * 1990-03-02 1991-09-05 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
US5221735A (en) * 1991-02-25 1993-06-22 Hoffmann-La Roche Inc. Cyclodextrin-polyene inclusion complexes
JPH06248193A (ja) * 1993-02-25 1994-09-06 Ensuiko Sugar Refining Co Ltd クロセチン含有着色料
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
CZ306394A3 (en) * 1993-12-14 1995-08-16 Lilly Co Eli Aqueous solution of inclusion complex of benzothiophene derivative with water-soluble cyclodextrins, process of its preparation and a pharmaceutical composition containing thereof
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6298558B1 (en) * 1994-10-31 2001-10-09 The Gillette Company Skin engaging member
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
WO1996040262A2 (en) * 1995-06-07 1996-12-19 The Procter & Gamble Company Process for preparing encapsulated water soluble beta-carotene
US5847108A (en) * 1996-03-21 1998-12-08 Fujicco Co., Ltd. Clathrate of isoflavone derivatives and edible composition comprising the same
RU2127686C1 (ru) * 1997-05-06 1999-03-20 Открытое акционерное общество "Павловский машиностроительный завод "Восход" Насосный гидропривод
WO1999044621A1 (en) * 1998-03-06 1999-09-10 Meiji Seika Kaisha, Ltd. Preventives/remedies for osteoporosis
JP4006133B2 (ja) 1999-05-17 2007-11-14 松谷化学工業株式会社 可溶性イソフラボン組成物及びその製造方法
US6458406B1 (en) 1999-12-17 2002-10-01 Mitsunori Ono Water-soluble bean-based extracts
US6541062B2 (en) 1999-12-17 2003-04-01 Mitsunori Ono Water-soluble soybean extracts
US7182972B2 (en) * 1999-12-17 2007-02-27 Quercegen Pharma, Llc Water-soluble bean-based extracts
JP4585074B2 (ja) * 2000-03-28 2010-11-24 ライオン株式会社 薬剤組成物の製造方法
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
DE10211192A1 (de) * 2002-03-14 2003-09-25 Beiersdorf Ag Isoflavanoide gegen Hautalterung und Akne
WO2004045541A2 (en) * 2002-11-15 2004-06-03 Cargill, Incorporated Soluble isoflavone compositions
US7157446B2 (en) * 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
KR100847225B1 (ko) 2003-10-24 2008-07-17 (주)아모레퍼시픽 사이클로 덱스트린의 분자 인식 기능을 이용한이소플라본의 추출방법
CN101528198A (zh) * 2006-11-03 2009-09-09 玉米制品国际有限公司 包胶的大豆提取物及其制备方法
JP4978209B2 (ja) * 2007-01-22 2012-07-18 株式会社イヅツみそ フリーズドライ味噌の製造方法
KR100929920B1 (ko) * 2007-09-05 2009-12-04 주식회사 마크로케어 사이클로덱스트린 및 이의 유도체에 소수성 생리활성성분이 포접된 포접체의 제조방법 및 이로써 제조된포접체의 용도
EP2106786A1 (de) * 2008-04-04 2009-10-07 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
EP2349234A1 (en) * 2008-11-24 2011-08-03 Berta, Giovanni Nicolao New formulations with anti-neoplastic activity
CN101757640B (zh) * 2009-06-09 2011-08-31 东华大学 一种鹰嘴豆异黄酮与环糊精包合物的制备
US9925274B2 (en) 2012-11-15 2018-03-27 Sapiotec Gmbh Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient
JP6234475B2 (ja) 2012-12-11 2017-11-22 ザピオテック・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＳＡＰＩＯＴＥＣ ＧｍｂＨ メラノーマ細胞に対抗するためのデルフィニジン
PL3565602T3 (pl) * 2017-01-09 2021-09-13 SciPharm S.à r.l. Nowy sposób wytwarzania rozpuszczalnej w wodzie forskoliny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949085A (en) * 1970-05-27 1976-04-06 Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
DE3485000D1 (de) * 1983-06-28 1991-10-10 Takeda Chemical Industries Ltd Gemahlene mischung.

Also Published As

Publication number Publication date
DD254939A5 (de) 1988-03-16
EP0214647B1 (de) 1993-03-24
SU1757472A3 (ru) 1992-08-23
FI863652A0 (fi) 1986-09-10
CS276944B6 (en) 1992-10-14
EP0214647A3 (en) 1987-09-30
KR900000542B1 (ko) 1990-01-31
EP0214647A2 (de) 1987-03-18
FI86958B (fi) 1992-07-31
CN86106889A (zh) 1987-07-15
DE3688114D1 (de) 1993-04-29
FI86958C (fi) 1992-11-10
PL261349A1 (en) 1987-06-29
ATE87319T1 (de) 1993-04-15
CA1288424C (en) 1991-09-03
CN1006889B (zh) 1990-02-21
HUT41759A (en) 1987-05-28
JPH0688993B2 (ja) 1994-11-09
UA19813A (uk) 1997-12-25
KR870002842A (ko) 1987-04-13
RU2022970C1 (ru) 1994-11-15
JPS62103077A (ja) 1987-05-13
HU199444B (en) 1990-02-28
US4826963A (en) 1989-05-02
FI863652L (fi) 1987-03-11
US5043326A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
MY101791A (en) New benzimidazole derivatives
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
DE3665717D1 (en) Complexes of flavanolignanes with phospholipids, preparation thereof and associated pharmaceutical compositions
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IE862554L (en) Pharmaceutical compositions
GR3004448T3 (cs)
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
MY101784A (en) Novel pharmacological compounds
IL84944A (en) Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
IL85312A0 (en) Improving the stability of pharmaceutical compositions
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
IT1150213B (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche
IL87089A (en) Derivatives of n-aminobutyl-n- phenylarylamides, their preparation and pharmaceutical compositions containing them
SE8600658D0 (sv) Novel composition of matter
DE3263832D1 (en) Gallium chloride, an anti-cancer drug
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
ES8703872A1 (es) Procedimiento para preparar derivados de isoquinolina.
IL71642A (en) Galactosylated human albumin conjugates of vinblastine derivatives,their preparation and pharmaceutical compositions containing them
GR850484B (cs)
JO1531B1 (en) New near-compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
AU6975891A (en) Pharmaceutical compositions for the treatment of drug dependence